AACR 2025

Apr 30, 2025

Scientific posters

AACR 2025

T-cell immunogenicity and biomarker profiling in advanced melanoma patients receiving the personalized vaccine EVX-01 in combination with pembrolizumab

ESMO IO 2024

Dec 12, 2024

Scientific posters

ESMO IO 2024

AI-designed cancer vaccines: antigens from the dark genome are promising cancer vaccine targets

ECCB 2024

Sep 25, 2024

Scientific posters

ECCB 2024

Advancing Vaccine Development through Precise AI-driven Prediction of Protective Antigens.

ESMO 2024

Sep 16, 2024

Scientific posters

ESMO 2024

Phase 2 study of AI-designed personalized neoantigen cancer vaccine, EVX-01, in combination with pembrolizumab in advanced melanoma

ASCO 2024

Jun 4, 2024

Scientific posters

ASCO 2024

Immunogenicity of an AI-designed personalized neoantigen vaccine, EVX-01, in combination with anti-PD1 therapy in patients with metastatic melanoma